Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paired related homeobox 1 (PRRX1) is a nuclear DNA-binding transcription factor belonging to the homeobox family, specifically the paired-related subclass[6]. It contains a homeodomain responsible for DNA interaction and transcriptional co-activator function, enhancing DNA-binding activity of other nuclear factors such as serum response factor[1]. PRRX1 plays essential roles in embryonic development, regulating cell fate decisions within mesenchymal tissues—particularly craniofacial and limb formation—and muscle differentiation through creatine kinase regulation[1][3]. Alternative splicing yields two main isoforms, PRRX1a and PRRX1b, with distinct C-terminal domains and partially overlapping functions: PRRX1a promotes cell migration, and PRRX1b supports cell proliferation and self-renewal[3]. PRRX1 acts as a critical orchestrator of epithelial–mesenchymal transition (EMT), supporting tumor cell dissemination, invasion, and metastatic colonization across multiple cancer types[7]. Its regulation of adipogenesis and osteoblast differentiation involves key pathways such as TGF-beta and TNF-alpha signaling[1]. PRRX1 directly controls expression of genes involved in inflammation, e.g., upregulating MMP13 and promoting barrier dysfunction in inflammatory bowel disease and ulcerative colitis[5]. Protein–protein interactions include binding to Ku70 (critical for DNA repair) and TOP2A (implicated in chromatin management and malignancy)[2][4]. PRRX1's expression pattern and activity make it both a developmental regulator and a pathologic mediator in cancer, inflammation, and tissue regeneration.
Not applicable; no drugs known to directly target PRRX1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paired related homeobox 1 (PRRX1).